When does the skin rash typically appear in Stevens-Johnson syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

When Does the Skin Rash Appear in Stevens-Johnson Syndrome?

The skin rash in Stevens-Johnson syndrome typically appears within 7 to 21 days after starting the causative drug, though it can develop as early as a few days or occasionally take several weeks. 1

Timeline of Clinical Presentation

Prodromal Phase (Before Rash)

  • An "influenza-like" prodromal illness precedes the rash, characterized by fever, malaise, upper respiratory tract symptoms, sore throat, and general discomfort 2, 3
  • This prodromal phase typically lasts 1-3 days before skin manifestations appear 2
  • Constitutional symptoms can occur without the rash initially, making early diagnosis challenging 2

Rash Onset and Progression

  • The rash typically begins on the face and chest (trunk), then spreads to other areas 2, 4
  • Initial lesions present as painful erythematous macules or atypical target lesions that rapidly progress 4, 1
  • The palmoplantar areas (palms and soles) are usually spared, which is an important distinguishing feature 4
  • Macular lesions become purplish and progress to epidermal detachment with flaccid blisters that converge and break 4

Temporal Relationship to Drug Exposure

  • The median time from drug initiation to cutaneous eruption is approximately 11 days for nevirapine-induced SJS/TEN, with two-thirds of cases occurring during the initial dosing period 2
  • The average timeframe across all causative drugs is 7 to 21 days after starting the offending medication 1
  • In some cases, symptoms may appear within the first week of therapy 2

Critical Clinical Features at Presentation

Mucosal Involvement

  • Mucosal involvement occurs in almost all patients and may precede or accompany the skin rash 1
  • The most frequently affected sites are the oropharynx (mouth ulcers), followed by eyes (conjunctivitis/iritis) and genitourinary tract 2
  • Painful mucosal erosions are a hallmark feature 2

Rash Characteristics

  • The rash manifests as a macular exanthema with "atypical targets" focusing on face, neck, and central trunk 5
  • Lesions show rapid confluence and a positive Nikolsky's sign (epidermal detachment with lateral pressure) 4, 5
  • Lesions may continue to erupt in crops for as long as 2 to 3 weeks 2

Important Clinical Pitfalls

Don't Miss Early Warning Signs

  • Patients may seek care before the rash appears, presenting only with prodromal symptoms 2
  • The presence of painful skin, sore eyes, or mouth ulcers should raise immediate suspicion even before widespread rash develops 2
  • Constitutional symptoms (fever, malaise) combined with a new medication started within the past 3 weeks should trigger heightened vigilance 2, 1

Document the Index Date

  • The "index date" is defined as when the patient developed the first symptom or sign (sore throat, rash, skin pain, sore eyes/mouth), not necessarily when the full rash appeared 2
  • This distinction is critical for determining the causative drug, as the culprit is typically started 7-21 days before the index date 1

Medication History is Essential

  • Record all medications taken over the previous 2 months, including over-the-counter and complementary/alternative therapies 2
  • Note any brand switches or medication errors, as these can be relevant 2
  • High-risk drugs include sulfonamides, anticonvulsants (carbamazepine, phenytoin), allopurinol, NSAIDs, and certain antibiotics 4, 5, 3

Immediate Actions When SJS is Suspected

  • Discontinue any potential culprit drug immediately upon suspicion—do not wait for confirmatory testing 2, 1
  • The course of the disease is often rapid and fatal, making early drug withdrawal the most important intervention 4
  • Prompt referral to an appropriate medical center (burn unit or intensive care unit) is mandatory 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Clinical reviews in allergy & immunology, 2018

Research

Stevens-Johnson syndrome and toxic epidermal necrolysis: a review.

Revista da Associacao Medica Brasileira (1992), 2016

Research

Drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.

American journal of clinical dermatology, 2000

Related Questions

What is the management of Steven Johnson syndrome caused by a drug?
What is the treatment for Steven's Johnson Syndrome (SJS)?
What is the treatment for Stevens-Johnson Syndrome (SJS)?
What is the management approach for a patient diagnosed with Stevens-Johnson (Toxic Epidermal Necrolysis) syndrome?
What medications can cause Stevens-Johnson syndrome (SJS)?
In hereditary hemochromatosis, which statement is true: a) reduced hepcidin expression is the primary cause; b) it is associated with diabetes mellitus; c) it is associated with chronic obstructive pulmonary disease; d) it usually presents in childhood with liver failure; e) liver damage is treated with chelating agents?
In primary (hereditary) hemochromatosis, which of the following statements is correct: reduced hepcidin expression, association with diabetes mellitus, association with chronic obstructive pulmonary disease, childhood onset with liver failure, or treatment of liver damage with chelating agents?
What is eszopiclone (Lunesta), how does it work, and is it safe for treating my insomnia given my current medications (tizanidine, clonazepam, buspirone, quetiapine, cariprazine, mixed‑amphetamine salts (Adderall), and semaglutide) and the risk of sleep‑related eating?
How is atherosclerotic cardiovascular disease (ASCVD) risk stratified in adults, including the risk categories, thresholds, and corresponding statin therapy recommendations?
In an adult chronic alcoholic with sensory‑predominant peripheral neuropathy and painful allodynia, can alpha‑lipoic acid be used as therapy?
How can I calculate minute ventilation (VE) and tidal volume (VT) for an adult patient using body surface area (BSA) based on height, weight, and sex?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.